To investigate whether infliximab has a steroid-sparing effect in the treatment of patients with polymyalgia rheumatica (PMR) who are resistant to corticosteroid (CS) therapy and have had CS-related side effects.
Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study / Salvarani, C., Cantini, F., Niccoli, L., Catanoso, M.G., Macchioni, P., Pulsatelli, L., Padula, A., Olivieri, I., Boiardi, L.. - In: THE JOURNAL OF RHEUMATOLOGY. - ISSN 0315-162X. - 30:4(2003), pp. 760-763.
Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study
SALVARANI, CARLO;
2003
Abstract
To investigate whether infliximab has a steroid-sparing effect in the treatment of patients with polymyalgia rheumatica (PMR) who are resistant to corticosteroid (CS) therapy and have had CS-related side effects.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
